Dallas, TX (PRWEB) March 19, 2008 ? MedSurge Advances, the nation's largest independent provider of aesthetic medicine products and services to physicians, today announced the availability of the EXELO2, the new ablative fractionated CO2 laser system. The EXELO2 is manufactured by Quantel Derma, formerly known as Wavelight. The EXELO2 will be exhibited at the upcoming ASLMS conference in Kissimmee, FL, Booth # 935.

The EXELO2 is revolutionary in its ability to combine the benefits of ablative and non-ablative lasers in one simple pain-free procedure. The fractionated CO2 technology creates wells in the skin which contracts the skin immediately. Besides the skin tightening capability, the heated areas around the wells causes neo-collagen formation resulting in a long term reduction in wrinkles and improved skin elasticity. Improvement in the appearance of pigmented lesions, such as solar damage, is also apparent. Traditional CO2 laser indications such as hypertrophic lesions are also easily treated. The EXELO2 offers several technological advances over competitive CO2 fractional laser devices.

Variable Spot Density and Depth Provide Better Patient Outcomes

The EXELO2's Computer Pattern Generator (CPG) technology with variable density allows the operator to adjust the spot density from 25 to 400 MTZ/cm2 and spot depth by increasing or decreasing the power. Controls are built-in to the handpiece, providing the ultimate in user-friendly design. Additionally, treatment areas can be increased up to 4 cm2. This unique flexibility allows the physician to determine the extent of micro-channel ablation. By determining the extent of ablation, the physician controls patient downtime and the number of treatments required to achieve a particular outcome (1-3 treatments depending on severity.) Typically, 1-5 days downtime are all that is required.

Powerful and Fast

With 30 Watts of power, the EXELO2 allows the physician maximum versatility and extremely fast treatment times. A full face treatment requires only 15 minutes and without the need for patient preparation time as no topical anesthetic is required.

Designed to Fulfill Physician Needs

The EXELO2 laser system has no disposables, providing physicians with greater profit potential for each procedure. Additionally, a concurrent integrated cooling system and built-in smoke evacuation make the EXELO2 an easy addition to aesthetic practices and require only a single clinician to perform procedures.

Jack Savage, CEO of MedSurge Advances, says, "We are not the first to bring CO2 fractional technology to physicians, but with the EXELO2, we are capable of delivering one device that incorporates the best of all possible fractional developments and to do so at a very attractive price - 30 watts of power, variable spot density and depth, integrated cooling and built-in smoke extraction all combine to make the EXELO2 a superior CO2 fractional system."

Designed to Provide Physicians with a Better ROI

Priced at well under $100,000 and with no disposable commitment cost, the EXELO2 allows physicians to recoup their initial investment at a much faster rate than competitive technologies.

The EXELO2 is pending FDA clearance.

About MedSurge Advances

Based in Dallas, MedSurge Advances helps physicians across the United States build and manage their practices in aesthetic medicine, one of the fastest-growing healthcare segments. Since its founding in 2002, MedSurge Advances has provided technology and business resources for more than 330 physicians in 42 states who have started stand-alone businesses or added aesthetic procedures to their existing practices. For more information, contact MedSurge Advances at 972.720.0425, or visit www.medsurgeadvances.com.